Consolidated figures · ₹ crore
| ₹ Cr | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 5,931 | 6,721 | 7,963 | 8,739 | 8,608 | 10,253 | 11,933 | 3,699 | 4,138 | 4,643 | |
| COGS | — | 2,059 | 2,420 | 2,635 | 2,549 | 2,892 | 3,532 | 916 | 938 | 1,049 |
| Gross profit | — | 4,662 | 5,543 | 6,103 | 6,060 | 7,362 | 8,401 | 2,783 | 3,200 | 3,594 |
| 5,599 | 4,047 | 4,680 | 4,846 | 4,993 | 5,878 | 6,835 | 2,216 | 2,455 | 2,730 | |
| 332 | 615 | 863 | 1,257 | 1,066 | 1,484 | 1,566 | 567 | 746 | 864 | |
| OPM % | 5.6% | 9.2% | 10.8% | 14.4% | 12.4% | 14.5% | 13.1% | 15.3% | 18% | 18.6% |
| Depreciation | 322 | 298 | 306 | 586 | 618 | 641 | 780 | 220 | 249 | 264 |
| Interest | 354 | 185 | 179 | 360 | 294 | 257 | 329 | 110 | 124 | 123 |
| 453 | 175 | 33 | 18 | 50 | 51 | 78 | 32 | 5,169 | 93 | |
| Profit before tax | 108 | 308 | 410 | 330 | 205 | 637 | 535 | 268 | 5,542 | 570 |
| Tax | — | 26 | 43 | 15 | 27 | 36 | 60 | 57 | 134 | 143 |
| Tax % | — | 8.5% | 10.5% | 4.7% | 13.3% | 5.6% | 11.1% | 21.1% | 2.4% | 25% |
| 98 | 282 | 367 | 315 | 178 | 601 | 475 | 212 | 5,408 | 427 | |
| PAT margin % | 1.6% | 4.2% | 4.6% | 3.6% | 2.1% | 5.9% | 4% | 5.7% | 130.7% | 9.2% |
| EPS (₹) | 2.2 | 5.8 | 6.6 | 5.5 | 3 | 10.6 | 8.6 | 2.6 | 108 | 7.5 |
| EPS adjusted (₹) | 2.5 | 5.3 | — | — | 3 | 10.5 | 8.5 | 2.6 | 107.7 | 7.5 |
| 0% | 0% | 0% | 0% | 0% | 0% | 0% | 4,615.4% | 4.6% | — | |
| Annual report | — | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2017 | Mar 2018 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 403 | 505 | 497 | 500 | 500 | 500 | 500 | 518 |
| Reserves | 1,472 | 2,327 | 2,875 | 3,454 | 3,949 | 4,060 | 2,929 | 4,058 |
| Minority interest | 375 | 358 | 462 | 529 | 412 | 470 | 223 | 258 |
| 2,721 | 2,212 | 2,309 | 2,192 | 2,287 | 669 | 642 | 701 | |
| 1,836 | 2,082 | 5,500 | 5,871 | 7,733 | 12,292 | 2,313 | 2,577 | |
| Total equity & liabilities | 6,807 | 7,484 | 11,643 | 12,546 | 14,881 | 17,991 | 6,606 | 8,112 |
| 3,520 | 3,738 | 4,581 | 4,704 | 9,052 | 3,175 | 3,920 | 2,902 | |
| CWIP | 290 | 402 | 934 | 978 | 255 | 170 | 291 | 413 |
| Investments | 22 | 25 | 63 | 45 | 80 | 17 | 245 | 1,167 |
| 2,976 | 3,320 | 6,065 | 6,820 | 5,494 | 14,629 | 2,151 | 3,631 | |
| Total assets | 6,807 | 7,484 | 11,643 | 12,546 | 14,881 | 17,991 | 6,606 | 8,112 |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Hospitals & Clinics | 4,506.39 | 780.42 | 6,711.99 | 2,937.45 | 3,774.54 | 20.68 |
| Labs | 153.5 | 14.84 |
| ₹ Cr | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 361 | 537 | 584 | 1,569 | 1,313 | 1,834 | 158 | 425 | 656 | |
| -1,153 | -523 | -692 | -330 | -570 | -972 | -885 | 6,015 | -288 | |
| 654 | 46 | 134 | -1,116 | -685 | -817 | 1,053 | -6,358 | -304 | |
| Net cash flow | -138 | 61 | 26 | 123 | 58 | 45 | 326 | 82 | 63 |
| Free cash flow | -564 | 20 | 16 | 1,195 | 830 | 1,117 | -639 | 79 | 187 |
| CFO / Operating profit % | 108.6% | 87.7% | 67.6% | 147.6% | 88.6% | 117.2% | 27.3% | 55.6% | 72.8% |
| 83.34 |
| 59.51 |
| 23.83 |
| 62.27 |
| Wholesale Pharmacies | 108.32 | 0.79 | 55.34 | 8.75 | 46.59 | 1.7 |
| Others | 14.79 | -17 | 26.62 | 0 | 26.62 | -63.86 |
| 0 | 0 | 0 | 0 | 0 | — | — |
₹ crore by fiscal year